Suppr超能文献

通过细胞体外方法检测铬过敏

Detection of chromium allergy by cellular in vitro methods.

作者信息

Lindemann M, Rietschel F, Zabel M, Grosse-Wilde H

机构信息

Institut für Immunologie, Universitätsklinikum Essen, Essen, Germany.

出版信息

Clin Exp Allergy. 2008 Sep;38(9):1468-75. doi: 10.1111/j.1365-2222.2008.02970.x. Epub 2008 Mar 31.

Abstract

BACKGROUND

The standard assay for the detection of chromium sensitization, the patch test, does not allow discrimination between patients with and without clinical symptoms of allergy.

OBJECTIVE

The aim of this study was to prove whether cellular in vitro tests are predictive of chromium allergy.

METHODS

Chromium-sensitized volunteers with and without clinically manifest allergy and non-sensitized healthy controls (n=37, 19, and 26, respectively) were analysed by cellular in vitro methods using tri- and hexavalent chromium (chromium chloride and potassium dichromate) as stimuli. The results were correlated with clinical and anamnestic data.

RESULTS

Sensitized individuals with an allergy displayed significantly higher lymphocyte transformation test (LTT) responses than sensitized volunteers without allergy and controls (P<0.05 and P<0.01, respectively). 12.5 microg/mL of chromium chloride and 50 ng/mL of potassium dichromate were found to be optimal to discriminate between sensitized individuals with and without allergy. Combining the results of chromium chloride and potassium dichromate LTT, a positive reaction to at least one of the stimuli was highly predictive of allergy [sensitization with vs. without allergy: Odds ratio (OR)=6.4, P=0.004; sensitization with allergy vs. controls: OR=11.5, P<0.0001]. On the contrary, IFN-gamma, IL-2, IL-4, IL-10, and IL-12 production to the ELISpot, patch test results, sensitization against other metals, and atopy score did not significantly discriminate between sensitization with and without allergy. However, IFN-gamma responses towards chromium chloride were significantly correlated with the strength of patch test reactivity (r=0.49, P=0.002). By IFN-gamma ELISpot, the average precursor cell frequency reactive to trivalent chromium could be defined as 26, 15, and 11 : 10(6) in volunteers with sensitization and allergy, with sensitization without allergy, and controls, respectively.

CONCLUSIONS

In contrast to the patch test, the LTT appears to be a method that is predictive of chromium allergy.

摘要

背景

用于检测铬致敏的标准检测方法——斑贴试验,无法区分有和没有过敏临床症状的患者。

目的

本研究的目的是证明细胞体外试验是否可预测铬过敏。

方法

采用细胞体外方法,以三价铬和六价铬(氯化铬和重铬酸钾)作为刺激物,对有和没有临床明显过敏症状的铬致敏志愿者以及未致敏的健康对照者(分别为n = 37、19和26)进行分析。将结果与临床和既往史数据进行关联。

结果

有过敏症状的致敏个体的淋巴细胞转化试验(LTT)反应显著高于没有过敏症状的致敏志愿者和对照者(分别为P < 0.05和P < 0.01)。发现12.5 μg/mL的氯化铬和50 ng/mL的重铬酸钾最适合区分有和没有过敏症状的致敏个体。结合氯化铬和重铬酸钾LTT的结果,对至少一种刺激物呈阳性反应高度预测过敏[有过敏症状的致敏与无过敏症状的致敏:优势比(OR)= 6.4,P = 0.004;有过敏症状的致敏与对照:OR = 11.5,P < 0.0001]。相反,酶联免疫斑点试验(ELISpot)检测的IFN-γ、IL-2、IL-4、IL-10和IL-12产生量、斑贴试验结果、对其他金属的致敏情况以及特应性评分,在有和没有过敏症状的致敏之间没有显著差异。然而,对氯化铬的IFN-γ反应与斑贴试验反应强度显著相关(r = 0.49,P = 0.002)。通过IFN-γ ELISpot,在有过敏症状的致敏志愿者、没有过敏症状的致敏志愿者和对照者中,对三价铬有反应的平均前体细胞频率分别可定义为26、15和11 : 10⁶。

结论

与斑贴试验不同,LTT似乎是一种可预测铬过敏的方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验